Siegfried Kasper

54.7k total citations · 3 hit papers
1.0k papers, 34.8k citations indexed

About

Siegfried Kasper is a scholar working on Psychiatry and Mental health, Pharmacology and Experimental and Cognitive Psychology. According to data from OpenAlex, Siegfried Kasper has authored 1.0k papers receiving a total of 34.8k indexed citations (citations by other indexed papers that have themselves been cited), including 341 papers in Psychiatry and Mental health, 320 papers in Pharmacology and 176 papers in Experimental and Cognitive Psychology. Recurrent topics in Siegfried Kasper's work include Treatment of Major Depression (300 papers), Bipolar Disorder and Treatment (152 papers) and Tryptophan and brain disorders (140 papers). Siegfried Kasper is often cited by papers focused on Treatment of Major Depression (300 papers), Bipolar Disorder and Treatment (152 papers) and Tryptophan and brain disorders (140 papers). Siegfried Kasper collaborates with scholars based in Austria, Germany and United States. Siegfried Kasper's co-authors include Rupert Lanzenberger, Stuart Montgomery, Hans‐Jürgen Möller, Dietmar Winkler, N. Praschak-Rieder, Matthäus Willeit, Joseph Zohar, Alexander Neumeister, Heinz Grunze and Eduard Vieta and has published in prestigious journals such as Proceedings of the National Academy of Sciences, JAMA and Journal of Biological Chemistry.

In The Last Decade

Siegfried Kasper

997 papers receiving 33.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Epidemiological Findings of Seasonal Changes in Mood and Behavior

1989 541 citations Siegfried Kasper et al. profile →
Serotonin and neuroplasticity – Links between molecular, functional and structural pathophysiology in depression

2017 321 citations Christoph Kraus, Siegfried Kasper et al. profile →
Prognosis and improved outcomes in major depression: a review

2019 285 citations Christoph Kraus, Rupert Lanzenberger et al. profile →

Peers

Countries citing papers authored by Siegfried Kasper

Since Specialization

Citations

This map shows the geographic impact of Siegfried Kasper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Siegfried Kasper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Siegfried Kasper more than expected).

Fields of papers citing papers by Siegfried Kasper

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Siegfried Kasper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Siegfried Kasper. The network helps show where Siegfried Kasper may publish in the future.

Co-authorship network of co-authors of Siegfried Kasper

This figure shows the co-authorship network connecting the top 25 collaborators of Siegfried Kasper. A scholar is included among the top collaborators of Siegfried Kasper based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Siegfried Kasper. Siegfried Kasper is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Mild motor signs and depression: more than just medication side effects? 2025 ·European Archives of Psychiatry and Clinical Neuroscience ·Antonina Luca, Maria Luca, Siegfried Kasper, Joseph Zohar, Daniel Souery, Stuart Montgomery, Panagiotis Ferentinos, Dan Rujescu, Julien Mendlewicz, Raffaella Zanardi, Raffaele Ferri, Bartolo Lanuzza, Basilio Pecorino, Bernhard T. Baune, Giuseppe Fanelli, Chiara Fabbri, Alessandro Serretti	0
2	Die Rolle von Phytotherapie bei COVID-19-assoziierter Angst und Depression 2024 ·Zeitschrift für Phytotherapie ·(unknown), Rainer Stange, Siegfried Kasper, Lucie Bartova	1
3	Silexan in anxiety, depression, and related disorders: pharmacological background and clinical data 2024 ·European Archives of Psychiatry and Clinical Neuroscience ·Siegfried Kasper, Anne Eckert	2
4	Baseline symptom severity and efficacy of Silexan in patients with anxiety disorders: A symptom-based, patient-level analysis of randomized, placebo-controlled trials 2024 ·European Psychiatry ·Markus Dold, Hans‐Jürgen Möller, Hans‐Peter Volz, Erich Seifritz, Sandra Schläfke, Lucie Bartova, Siegfried Kasper	3
5	Effects of bilateral sequential theta-burst stimulation on functional connectivity in treatment-resistant depression: First results 2023 ·Journal of Affective Disorders ·(unknown), Godber Mathis Godbersen, Murray Bruce Reed, Jakob Unterholzner, Manfred Klöbl, P. Baldinger, Thomas Vanicek, Andreas Hahn, Rupert Lanzenberger, Siegfried Kasper, Georg S. Kranz	14
6	Age as a moderating factor of treatment resistance in depression 2023 ·European Psychiatry ·Alexander Kautzky, Lucie Bartova, Gernot Fugger, Markus Dold, Daniel Souery, Stuart Montgomery, Joseph Zohar, Julien Mendlewicz, Chiara Fabbri, Alessandro Serretti, Dan Rujescu, Siegfried Kasper	4
7	Cariprazine for treating psychosis: an updated meta-analysis 2022 ·International Journal of Psychiatry in Clinical Practice ·(unknown), (unknown), (unknown), Pedro Shiozawa, Siegfried Kasper	1
8	Sick leave duration as a potential marker of functionality and disease severity in depression 2022 ·International Journal of Psychiatry in Clinical Practice ·Hans‐Peter Volz, (unknown), Lucie Bartova, João M. Bessa, Domenico De Berardis, Jozef Dragašek, (unknown), Maria Ladea, Judit Lazáry, Miquel Roca, (unknown), Adam Wichniak, Brian Godman, Siegfried Kasper	9
9	Incidence of Drug-Induced Delirium During Treatment With Antidepressants or Antipsychotics: A Drug Surveillance Report of German-Speaking Countries Between 1993 and 2016 2022 ·The International Journal of Neuropsychopharmacology ·Michaela‐Elena Friedrich, R. Grohmann, Ulrich Rabl, Dietmar Winkler, Anastasios Konstantinidis, Rolf R. Engel, Johanna Seifert, Sermin Toto, Susanne Stübner, Richard Frey, Siegfried Kasper	7
10	Reliability of task-specific neuronal activation assessed with functional PET, ASL and BOLD imaging 2021 ·Journal of Cerebral Blood Flow & Metabolism ·Lucas Rischka, Godber Mathis Godbersen, Verena Pichler, Paul Michenthaler, (unknown), Manfred Klöbl, (unknown), Wolfgang Wadsak, Marcus Hacker, Siegfried Kasper, Rupert Lanzenberger, Andreas Hahn	18
11	Combining machine learning algorithms for prediction of antidepressant treatment response 2020 ·Acta Psychiatrica Scandinavica ·Alexander Kautzky, (unknown), Markus Dold, Lucie Bartova, Florian Seemüller, Gerd Laux, Michael Riedel, Wolfgang Gäebel, Siegfried Kasper	33
12	Dose‐response relationship of selective serotonin reuptake inhibitors 2020 ·Acta Psychiatrica Scandinavica ·Markus Dold, Siegfried Kasper	1
13	Constant Degradation of the Androgen Receptor by MDM2 Conserves Prostate Cancer Stem Cell Integrity 2019 ·Cancer Research ·Premkumar Vummidi Giridhar, Karin Williams, Andrew VonHandorf, (unknown), Siegfried Kasper	37
14	DiGeorge syndrome 2018 ·Wiener klinische Wochenschrift ·Christoph Kraus, Thomas Vanicek, (unknown), (unknown), M. Stamenković, Rupert Lanzenberger, Matthäus Willeit, Siegfried Kasper	10
15	PS183. Effect of electroconvulsive therapy on monoamine oxidase A binding - a preliminary report 2016 ·The International Journal of Neuropsychopharmacology ·P. Baldinger, Gregory M. James, Marius Hienert, (unknown), L. Silberbauer, Wolfgang Wadsak, Andreas Hahn, Markus Mitterhauser, Siegfried Kasper, Richard Frey, Rupert Lanzenberger	1
16	A gap analysis for future supply of and demand for psychiatrists in Austria. 2014 ·PubMed ·Monika Riedel, (unknown), Thomas Czypionka, Siegfried Kasper	2
17	Prostate Cancer Cells with Stem Cell Characteristics Reconstitute the Original Human Tumor In vivo 2007 ·Cancer Research ·Guangyu Gu, Jialing Yuan, Marcia L. Wills, Siegfried Kasper	283
18	Pharmacokinetic-Pharmacodynamic Modeling of Tolerance to the Prolactin-Secreting Effect of Chlorprothixene after Different Modes of Drug Administration 1999 ·Journal of Pharmacology and Experimental Therapeutics ·M. Bagli, Richard Süverkrüp, (unknown), G. Höflich, Siegfried Kasper, Holger Jon Møller, Michael Langer, (unknown), (unknown)	14
19	[Therapeutic sleep deprivation and phototherapy]. 1999 ·PubMed ·N. Praschak-Rieder, Matthäus Willeit, Alexander Neumeister, Eva Hilger, Siegfried Kasper	8
20	Molecular Cloning and Hormonal Regulation of a Murine Epididymal Retinoic Acid-Binding Protein Messenger Ribonucleic Acid 1998 ·Endocrinology ·(unknown), (unknown), Guang-Quan Zhao, Siegfried Kasper, Marcia E. Newcomer, Robert J. Matusik, David E. Ong, Marie‐Claire Orgebin‐Crist	44

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact